LES Foundation | LESI | Print Page | Contact Us | Sign In | Join
How to Access Mayo Technology and Innovations and Clinical Expertise
Tell a Friend About This EventTell a Friend

LES Minnesota Chapter Meeting

When: Tuesday, December 15, 2015
11:30 am - 1:00 pm
Where: Hamline University, West Location
1600 Utica Avenue South
7th Floor
St Louis Park, Minnesota  55416
United States

« Go to Upcoming Event List  

Tuesday, December 15, 2015
11:30 am - 1:00 pm

How to Access Mayo Technology and Innovations and Clinical Expertise

The Mayo Clinic is more than just a world class provider of health care services.  Mayo is also a powerful engine of research and innovation. Nearly one half of Mayo Clinic technology disclosures in the last ten years have been licensed.  This presentation will discuss ways organizations can work with Mayo to advance their research and development efforts and bring new technologies to market.  Learn how to find the right technologies in Mayo’s vast portfolio of inventions and how to turn those inventions into viable and valuable medical solutions. Also learn how companies and entrepreneurs can access the clinical expertise and know-how of Mayo physicians to advance their innovations.  Recent agreements where Mayo has partnered with start-ups and large companies will be reviewed.

Andrew Danielsen, Mayo Clinic Ventures

Hamline University, West Location
7th Floor
1600 Utica Avenue South
St Louis Park, MN 55416

LES Member:        $40
LES Non-member: $55

Online Registration Deadline: Monday, December 14, 2014 12 pm CST 

No refunds after December 14
Substitutions are permitted

Andrew Danielsen
has been with Mayo Clinic Ventures since 2002 and directs the Technology Development and Business Development teams, assisting in seeking out and developing new business and technology commercialization opportunities. Prior to joining the office, Danielsen was a senior research technician at Mayo Clinic, where he conducted cancer research and identified novel aspects of signal transduction pathways that emanated from oncogenic EGF receptors. He received a B.S. in biochemistry and molecular biology from the University of Wisconsin-Eau Claire and an M.S. in molecular biology from the Mayo Graduate School of Medicine and is a registered patent agent.